The latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus functions as a constitutively activated receptor of the tumor necrosis factor receptor family. LMP1 is a short-lived protein that is ubiquitinated and degraded by the proteasome. We have previously shown that LMP1 recruits the adapter protein tumor necrosis factor receptor-associated factor 3 (TRAF3) to lipid rafts. To test if TRAFs are involved in LMP1's ubiquitination, we have mutated the LMP1 CTAR1 site that has been identified as a TRAF binding site. We show that the CTAR1 mutant (CTAR1 À ) is expressed after transfection at a similar level to wild-type LMP1, and behaves as wildtype LMP1 with respect to membrane localization. However, CTAR1
The latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus functions as a constitutively activated receptor of the tumor necrosis factor receptor family. LMP1 is a short-lived protein that is ubiquitinated and degraded by the proteasome. We have previously shown that LMP1 recruits the adapter protein tumor necrosis factor receptor-associated factor 3 (TRAF3) to lipid rafts. To test if TRAFs are involved in LMP1's ubiquitination, we have mutated the LMP1 CTAR1 site that has been identified as a TRAF binding site. We show that the CTAR1 mutant (CTAR1 À ) is expressed after transfection at a similar level to wild-type LMP1, and behaves as wildtype LMP1 with respect to membrane localization. However, CTAR1
À does not bind TRAF3. We demonstrate that ubiquitination of CTAR1 À is significantly reduced when compared to wild-type LMP1. In addition, the expression of wild-type LMP1 induces the ubiquitination, an effect that is significantly reduced when the CTAR1 À is expressed. Taken together, our results suggest that TRAF proteins are involved in the ubiquitination of LMP1, and that their binding to LMP1 may facilitate their own ubiquitination. Oncogene (2003 Oncogene ( ) 22, 5614-5618. doi:10.1038 Keywords: LMP1; ubiquitin; TRAF3; lipid rafts The latent membrane protein 1 (LMP1), encoded by the Epstein-Barr virus (EBV), was identified as an oncogene because of its capacity to transform rodent fibroblast cell lines in culture (Wang et al., 1985; Baichwal and Sugden, 1988) and to induce lymphomas in transgenic mice (Kulwichit et al., 1998) . LMP1 is expressed in tumor cells from several human malignancies associated with EBV, such as nasopharyngeal carcinoma, Hodgkin's disease and other atypical lymphoproliferative disorders, suggesting that this oncoprotein plays a determinant role in the pathogenesis of these diseases. LMP1 is a powerful inducer of NF-kB-mediated transcription (Hammarskjold and Simurda, 1992) and engages signaling proteins of the tumor necrosis factor receptor-associated factor (TRAF) family (Mosialos et al., 1995) . LMP1 is a short-lived protein with a reported half-life ranging from 1.5 to 7 h, depending on the cell type used (Baichwal and Sugden, 1987; Mann and Thorley-Lawson, 1987; Martin and Sugden, 1991) , is ubiquitinated and degraded by the proteasome (Aviel et al., 2000) .
There are seven lysine residues in ubiquitin, of which five have been implicated in polyubiquitin chain assembly. Chains linked through Lys-48 are the principal signal for proteolysis by the proteasome (Hofmann and Pickart, 2001) . In order to stabilize the ubiquitin-conjugated products, and ultimately to detect ubiquitin-conjugated LMP1, we generated an expression vector encoding ubiquitin mutated at lysine 48 (K48RUb). HEK 293 cells were cotransfected with expression vector encoding LMP1 and/or N-terminal Flag-tagged ubiquitin. After cell lysis and immunoprecipitation of LMP1, the ubiquitin-conjugated products were visualized by Western blotting with anti-Flag antibodies. Cotransfection of the wild-type ubiquitin construct, as expected, induced a slight decrease in the high molecular forms of LMP1 expressed in the cells. In constast, coexpression of K48RUb induced a slight increase in these forms, and did allow the detection of the ubiquitin-conjugated LMP1 proteins, that represent a minor fraction of the total LMP1 (Figure 1a ).
LMP1 has been recently shown to partition constitutively in lipid rafts in lymphoid and epithelial cells (Clausse et al., 1997; Higuchi et al., 2001; Rothenberger et al., 2002) . These specialized plasma membrane domains have been shown to function as signal transduction centers (Ilangumaran et al., 2000; Simons and Toomre, 2000; Cherukuri et al., 2001) . They may also play a role in the downregulation of receptors. We therefore wanted to determine whether it is possible to detect ubiquitin-conjugated LMP1 from isolated lipid rafts. One of the biochemical properties of lipid rafts is their partial resistance to solubilization by nonionic detergents such as Triton X-100 in which they form sphingolipid-enriched complexes at 41C. Owing to their high lipid content, these membranes are of low buoyant density and can be isolated from cells by density gradient centrifugation (Brown and London, 1998) . We coexpressed LMP1 and K48RUb in HEK293 cells, and fractionated the cell lysates by sucrose gradient centrifugation as described previously (Rothenberger et al., 2002) . The fractions containing the lipid rafts were pooled and solubilized in RIPA buffer. LMP1 was subsequently immunoprecipitated and the proteins resolved on SDS-PAGE. Western blot analysis of the samples revealed the presence of Flag-tagged ubiquitinconjugated LMP1 molecules in the lipid rafts ( Figure 1b We have shown recently that LMP1 binds endogenous TRAF3 and recruits it to lipid rafts (Rothenberger et al., 2002) . TRAF3 belongs to a family of proteins (TRAF1-6) that transduce signals leading to JNK/NFkB activation (Bradley and Pober, 2001; Wajant et al., 2001; Chung et al., 2002) . All TRAFs share a C-terminal homology region termed the TRAF domain that is capable of binding to the cytoplasmic domain of various members of the TNFR superfamily and which also mediates interactions with other TRAFs. The Nterminal region of TRAFs contains variable numbers of RING and zinc-finger motifs. LMP1 was shown to bind TRAF1, 2, 3 and 5 (Mosialos et al., 1995) , and a minor consensus sequence for TRAF binding has been defined in the LMP1 C-terminal CTAR1 region (Ye et al., 1999) . Recently, a structural homology has been found between TRAF2 and the ubiquitin ligase Shia (Polekhina et al., 2002) , and an ubiquitin ligase activity has been demonstrated for TRAF6 (Deng et al., 2000; Wang et al., 2001) , raising the question whether one or several members of the TRAF family could mediate the ubiquitination of LMP1. To test this hypothesis, we mutated the CTAR1 site containing the minor consensus region for TRAF binding and analysed the effect of this mutation on the ubiquitination of LMP1. The LMP1 CTAR1 site (PQQATD) was modified to (LQLAAD) by double PCR reactions and the presence of the mutations verified by sequencing. Although expressed at a similar level to wild-type LMP1, CTAR1 À only minimally activated NF-kB ( Figure 2a ). As expected, the mutation prevented the binding of TRAF3, as shown in coimmunoprecipitation experiments ( Figure 2b ). We further analysed the presence of CTAR1 À in lipid rafts from transfected cells by performing sucrose gradient fractionation. We found that CTAR1
À behaved as wild-type LMP1 with respect to membrane localization, suggesting that the binding of TRAF proteins is not essential for the lipid raft targeting of LMP1 (Figure 2c ). Caveolin-1 (cav), known to specifically partition in sphingolipid-and cholesterolrich microdomains, was exclusively present in the lowdensity fraction 4 as well as in the pellet. In contrast, the transferrin receptor (TR), which is excluded from lipid rafts, was found in high-density fractions. Most of the proteins were recovered in the high-density fractions as shown by the Ponceau Red staining of the nitrocellulose membrane (data not shown). As expected, TRAF3 was recruited to lipid rafts when LMP1 was expressed, but not when CTAR1 À was expressed. We further determined the ubiquitination pattern of CTAR1 À using the coexpression system with K48RUb. When compared to wild-type LMP1, the ubiquitination pattern of CTAR1 À was severely reduced (Figure 2d ). These results indicate that the ubiquitination of LMP1 depends on the integrity of the TRAF binding site. To detect ubiquitinated LMP1, HEK 293 cells grown on 9-cm Petri dishes were transfected with 2.5 mg of the LMP1 expression vector and 0.5 mg of a plasmid coding for either wild-type Flag-tagged ubiquitin (WTUb) or a Flag-tagged lysine 48 to arginine-mutant ubiquitin (K48RUb). The cells were lysed 24 h later in 0.25 ml denaturing solution containing 50 mm Tris-HCl pH 7.5, 0.5 mm EDTA and 1% SDS. After heating the samples for 10 min at 1001C, 1.5 ml of CHAPS buffer with protease inhibitors (10 mg/ml benzamidine, 2 mg/ml antipain, 1 mg/ml leupeptin, 2 mg/ml E-64) was added before performing the immunoprecipitations. Proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The ubiquitin-modified LMP1 molecules were visualized with an anti-Flag antibody. The expression of LMP1 was analysed in cell lysates (a). Cells grown on 15-cm Petri dishes were transfected with one or both plasmids coding for LMP1 and K48RUb. The cells were lysed 24 h later and the homogenates separated on a sucrose gradient. The fractions 3-5 containing the lipid rafts were pooled and solubilized in RIPA buffer (1% NP-40, 50 mm Tris-HCl pH 7.4, 0.15 m NaCl, 1% deoxycholate, 0.1% SDS, 5 mm EDTA with protease inhibitors (10 mg/ml benzamidine, 2 mg/ml antipain, 1 mg/ml leupeptin, 2 mg/ml E-64). LMP1 was immunoprecipitated and the proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The ubiquitinmodified LMP1 molecules were visualized with an anti-Flag antibody (b). In the complementary experiment, Flag-tagged proteins were immunoprecipitated and LMP1 detected in the immunoblot. IgH: position of the immunoglobulin heavy chain et al., 2002). We therefore investigated if LMP1 could have an effect on the ubiquitination and degradation of the TRAF proteins. When ubiquitination of the endogenous TRAF3 was monitored by coexpressing K48RUb, TRAF3 conjugation was detected only in the presence of LMP1, but not in the presence of CTAR1 À (Figure 3a) . These findings indicate that the ubiquitination of TRAF3 is increased upon binding to LMP1.
We observed a recruitment of the cytoplasmic TRAF3 to lipid rafts upon the expression of LMP1 (Figure 2c) . After subcellular fractionation, ubiquitinated TRAF3 predominantly localized in the membrane fraction, indicating that ubiquitin-conjugated TRAF3 is membrane-associated and not cytoplasmic (Figure 3b ). These results suggest that TRAF3 becomes ubiquitinated after binding to LMP1 in lipid rafts.
The ubiquitin conjugation system is controlled by three enzymatic steps: E1, E2 and E3. The E3 enzyme, ubiquitin ligase, plays a major role in the selection of a protein for conjugation and subsequent degradation, yet only a limited number of such enzymes have been identified so far, and little is known of their mode of action and cellular localization (Hicke, 1999; Ciechanover et al., 2000) . Interestingly, the ubiquitin ligases Cbl and Nedd-4 were recently found to be associated with lipid rafts after activation of IgE signaling (Lafont and Simons, 2001 ). The TRAF3 sequence contains a RING finger domain in its N-terminal region and therefore could potentially mediate a ubiquitin ligase activity (Joazeiro and Weissman, 2000) . We have constructed two forms of TRAF3: ND91TRAF3 has a deletion of the N-terminal region containing the RING finger and C76ATRAF3 has a cysteine 76 to alanine point mutation impairing the formation of the RING finger. Both constructs inhibited the LMP1-induced NF-kB activation when expressed in HEK293 cells (Figure 3c ). Such an inhibition was not observed when a control plasmid was cotransfected (data not shown). These TRAF3 mutants also inhibited the ubiquitination of LMP1 (Figure 3d ), suggesting that they can act as dominant negatives for both the activation of NF-kB and the ubiquitination of LMP1.
Taken together, our results suggest that TRAF3, either alone or with combination of other TRAFs, is involved in the ubiquitination of LMP1, and that the binding of TRAF3 to LMP1 facilitates its own Figure 2 The ubiquitination of the CTAR1 À mutant is reduced. Cells grown on six-well Petri dishes were cotransfected with either LMP1 or CTAR1 À (500 ng) and the NF-kB-inducible reporter plasmid 3 Â -kB-L (250 ng). The activity of the luciferase enzyme was determined in the cell lysates 24 h after the transfection as described previously (Rothenberger et al., 2002) . An aliquot of the lysates was analysed of by SDS-PAGE and Western blotting to compare the level of expression of LMP1 and CTAR1 À (a). Cells grown on 9-cm petri dishes were transfected with either LMP1 or CTAR1 À . After 24 h, the cells were harvested and lysed for 30 min on ice in CHAPS buffer (5 mm CHAPS, 10 mm Tris-HCl pH 7.4, 0.15 m NaCl, 2 mm MgCl 2 , 5 mm EGTA) with protease inhibitors (10 mg/ml benzamidine, 2 mg/ml antipain, 1 mg/ml leupeptin. LMP1 was immunoprecipitated with S12 antibodies immobilized to protein A-Sepharose. Proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Endogenous TRAF3 co-immunoprecipitated with LMP1 was detected with anti-TRAF3 antibody. IgH: position of the immunoglobulin heavy chains (b). Cells grown on 15-cm Petri dishes were transfected with either LMP1 or CTAR1
À . The cells were lysed 24 h later and the homogenates separated through a sucrose gradient. Aliquots of the collected fractions were resolved by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were incubated with the appropriate antibodies to reveal LMP1 or CTAR1 À , TRAF3, the transferrin receptor (TR), or caveolin-1 (cav) (c). Cells grown on 9-cm Petri dishes were transfected with 2.5 mg of LMP1 or CTAR1 À and 0.5 mg K48RUb. The cells were lysed 24 h later as described in Figure 1a , LMP1 was immunoprecipitated, and proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The ubiquitin-modified LMP1 molecules were visualized with an anti-Flag antibody (d) ubiquitination. The role of ubiquitin in protein degradation is well documented. However, recent data indicate ubiquitin may be involved in other processes, such as internalization of plasma membrane proteins (Strous and Govers, 1999) and signal transduction. A direct role of ubiquitin in the activation of a signaling pathway has been revealed by the study of TRAF6, a signal transducer in the NF-kB pathway, that activates IkB kinases (IKK) in response to inflammatory cytokines. TRAF6 was shown to function as an ubiquitin ligase that mediates the assembly of K63-linked polyubiquitin chains required for IKK activation (Deng et al., 2000; Wang et al., 2001) . According to the authors, these findings do not exclude that the target proteins conjugated by K63 chains are not ultimately degraded, but they indicate that degradation, even if it occurs, is not necessary for IKK activation. Although LMP1 was shown to be degraded by a proteasome-dependent manner (Aviel et al., 2000) , TRAF3 does not appear to be degraded after LMP1-induced signaling (Brown et al., 2001) . Further studies will help us to understand whether the ubiquitination of LMP1 and TRAF3 plays a role in an activation process that is important for signaling.
Figure 3 LMP1 induced the ubiquitination of TRAF3. Cells from 9-cm Petri dishes were co-transfected with 0.5 mg of K48RUb and 2.5 mg of the plasmid coding for LMP1 or CTAR1
À . The cells were lysed as described in Figure 1a . Endogenous TRAF3 was immunoprecipitated with anti-TRAF3 antibodies immobilized to protein A-Sepharose. Proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The ubiquitin-modified TRAF3 molecules were visualized with an anti-Flag antibody. The expression level of TRAF3, and LMP1 or CTAR1 À was analysed in the cell lysate (a). Cells from 15-cm Petri dishes were transfected with 0.5 mg K48RUb and 2.5 mg of the plasmid coding for LMP1. The cells were homogenized and fractionated as described in Rothenberger et al. (2002) . LMP1 or TRAF3 were immunoprecipitated from the high-speed pellet containing cellular membranes (M), and the high-speed supernatants containing cytosolic components (C). Ubiquitinated products were visualized with the anti-Flag antibody. Aliquots of the isolated fractions were analysed by SDS-PAGE. The transferrin receptor (TR) and caspase-3 were detected using the appropriate antibodies and were used as control for a membrane and cytosolic localization, respectively (b). Cells grown on six-well Petri dishes were cotransfected with LMP1 (500 ng) and either ND91TRAF3 or C76ATRAF3 (250 ng) and the NF-kB-inducible reporter plasmid 3x-kB-L (250 ng). The activity of the luciferase enzyme was determined in the cell lysates 24 h after the transfection as described previously (Rothenberger et al., 2002) . An aliquot of the lysates was analysed by SDS-PAGE and Western blotting to analyse the expression level of LMP1 and the VSV-tagged TRAF3 mutants (c). Cells from 9-cm Petri dishes were cotransfected with 0.5 mg of K48RUb, 2.5 mg of the plasmid coding for LMP1 and 0.25 mg of either ND91TRAF3 or C76ATRAF3. The cells were lysed as described in Figure 1a , and LMP1 was immunoprecipitated with anti-LMP1 antibodies immobilized to protein A-Sepharose. Proteins were resolved by SDS-PAGE, transferred to a nitrocellulose membrane, and the ubiquitin-modified LMP1 molecules were visualized with an anti-Flag antibody. The expression of LMP1 and the TRAF3 mutants was analysed in cell lysates (d)
